Because anti-rejection medications intentionally weaken your immune defenses, most transplant programs prescribe a specific set of preventive anti-infective medications after transplant — taken on a schedule while you feel completely well, specifically to prevent infections your suppressed immune system would otherwise be more vulnerable to. This is a genuinely different concept from an antibiotic course for an active infection: you take these on schedule because you're at risk, not because you're already sick.
What It Covers
CMV (cytomegalovirus) prophylaxis
- Valganciclovir (Valcyte) is the standard choice, dosed for a period based on your personal CMV risk category — commonly 3–6 months, extended toward 12 months for the highest-risk donor/recipient combination. (See CMV Disease & Monitoring After Transplant for the full detail on risk categories and monitoring.)
Pneumocystis jirovecii pneumonia (PJP/PCP) prophylaxis
- Trimethoprim-sulfamethoxazole (Bactrim, Septra) is the standard first-line choice, and it also happens to cover toxoplasmosis prevention at the same time, which is why it's often the single preferred agent for both.
- For patients with a sulfa allergy, alternatives include dapsone, atovaquone, or inhaled pentamidine (given periodically at an infusion center rather than as a daily pill).
- Unlike CMV prophylaxis, PJP prophylaxis is often continued for the entire duration of significant immunosuppression — sometimes indefinitely — since this particular risk doesn't meaningfully decline the way CMV risk does after the first year.
Antifungal prophylaxis
- A topical or oral antifungal (such as nystatin or clotrimazole troches) is commonly used in the early months to prevent oral thrush, when immunosuppression is at its most intense.
- Higher-risk patients may be prescribed a broader antifungal medication for a defined period, based on your specific risk factors and your center's protocol.
Why the Duration Varies by Medication
Each of these has its own timeline because the underlying risk behaves differently: CMV risk is highest early and is specifically tied to your donor/recipient serostatus, so that prophylaxis has a defined end date individualized to your risk category. PJP risk tracks more closely with your ongoing overall level of immunosuppression rather than time since transplant specifically, which is why that prophylaxis often continues much longer. Ask your own transplant team for your specific plan and duration, since practices vary somewhat by center.
What to Know About Side Effects
- Valganciclovir — can suppress bone marrow function, most often showing up as a drop in white blood cell count; monitored with regular blood counts, and your dose may be adjusted if your counts fall
- Trimethoprim-sulfamethoxazole — can affect kidney function and raise potassium levels (worth knowing since some anti-rejection and heart failure medications do the same, so your team watches this combination specifically), can cause GI upset, and can trigger an allergic reaction in people with a sulfa sensitivity
- Your transplant pharmacist reviews all of these alongside your anti-rejection medications for interactions (see Transplant Anti-Rejection Medications) — for example, trimethoprim-sulfamethoxazole and calcineurin inhibitors both can affect kidney function and potassium, which is exactly why this combination gets specific monitoring rather than being assumed to be fine
Why You Shouldn't Stop These Early
This is worth being direct about: because you're taking these while asymptomatic, it's tempting to feel like a missed dose or an early stop "doesn't matter" the way it might with, say, a course of antibiotics you finished treating a resolved infection. It matters quite a bit here — these medications are actively protecting you during a defined window of highest vulnerability, and stopping early (running out and delaying a refill, or deciding you "probably don't need it anymore") measurably raises your risk of the exact infections they're designed to prevent. If side effects are a genuine problem, the right move is calling your transplant team to discuss an alternative — not stopping on your own.
Common Questions
Why am I taking medication to prevent an infection I don't have?
Because your immunosuppression makes certain infections meaningfully more likely during specific windows after transplant — these medications prevent that risk proactively, rather than treating an infection after it develops.
Can I stop early if I'm feeling great?
No — feeling well doesn't mean the underlying risk has gone away; follow your transplant team's specific timeline, and talk to them directly if you want to understand why your particular duration was chosen.
Will I be on all of these forever?
Not necessarily — CMV and antifungal prophylaxis are typically time-limited based on your risk category, while PJP prophylaxis often continues for as long as you're on significant immunosuppression; your team will explain your specific plan.
What if I have a sulfa allergy?
Tell your transplant team specifically — there are effective alternatives for PJP prevention, so this doesn't mean going without protection.